跳至主要内容
临床试验/NCT05984771
NCT05984771已完成不适用

Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B2, B6, E, Mg, Zn and Palmitoylethanolamide for 6 Months in Patients With Diabetic Neuropathy : A Pilot Study

Aristotle University Of Thessaloniki1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2021年1月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
Nerve conduction study to measure the velocity of the nerve impulse in the sural nerve

研究概览

简要总结

To investigate the efficacy of Superoxide Dismutase (SOD, 70 UI), Palmitoylethanolamide (PEA, 300 mg) Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5 mcg), E (7.5 mg), Nicotinamide (9 mg) and minerals (Mg 30 mg, Zn 2,5 mg) in one tablet in patients with Diabetic Neuropathy (DN).

详细描述

To investigate the efficacy of Superoxide Dismutase (SOD, 70 UI), Palmitoylethanolamide (PEA, 300 mg) Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5 mcg), E (7.5 mg), Nicotinamide (9 mg) and minerals (Mg 30 mg, Zn 2,5 mg) in one tablet in patients with Diabetic Neuropathy (DN).

Patients - methods: In this pilot study, 61 patients with Diabetes Mellitus Type 2 (DMT2, 31 women), with mean duration of DM 17.5 years and mean age 63 years were randomly assigned, either to receive the combination of ten elements (2 tablets/24h) in the active group, (n=30), or the placebo (n=31) for 6 months. We used Michigan Neuropathy Screening Instrument Questionnaire and Examination (MNSIQ and MNSIE), measured vibration perception threshold (VPT) and Cardiovascular Autonomic Reflex Tests (CARTs). Nerve function was assessed by DPN Check [sural nerve conduction velocity (SNCV) and amplitude (SNAP)]. Sudomotor function was assessed with SUDOSCAN that measures electrochemical skin conductance in hands and feet (ESCH and ESCF). Pain (PS) questionnaire was administered, also. All patients received metformin for at least 4 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The investigator and examiner did not know the type of drug provided

入排标准

性别
Female
接受健康志愿者
否

入选标准

  • •on metformin therapy for at least 4 years
  • •diabetes mellitus type 2 with diabetic neuropathy
  • •painful neuropathy

排除标准

  • •without diabetic neuropathy

研究组 & 干预措施

Active group

Active Comparator

10-element combination tablet (n=30) Superoxide Dismutase (SOD, 70 UI), Palmitoylethanolamide (PEA, 300 mg) Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5 mcg), E (7.5 mg), Nicotinamide (9 mg) and minerals (Mg 30 mg, Zn 2,5 mg) in one tablet for 6 months

干预措施: Epineuron (Dietary Supplement)

Placebo

Placebo Comparator

usual care

干预措施: Placebo group (Other)

结局指标

主要结局

Nerve conduction study to measure the velocity of the nerve impulse in the sural nerve

时间窗: 6 months

Measurement of nerve conduction velocity with Neurometrix Diabetic Peripheral Neuropathy scan device

Michigan Screening Neuropathy Questionnaire and Examination

时间窗: 6 months

use of michigan screening questionnaire and examination

Measurement of individual Vibration Perception Threshold to study vibration perception in the feet

时间窗: 6 months

Measurement of vibration perception threshold with Biothesiometer

Measurement of electrochemical skin conductance

时间窗: 6 months

measurement with Sudoscan the electrochemical skin conductance in hands and feet

次要结局

  • vitamin B12 levels(6 months)
  • Glycated Hemoglobin(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Triantafyllos Didangelos

Professor of Internal Medicine and Diabetology

Aristotle University Of Thessaloniki

研究点 (1)

Loading locations...

相似试验